Concepedia

Guillaume Feugère

GF

Statistics

Publications

3

Citations

92

H-Index

3

Active since

2013

Affiliations

Pfizer (United States)(Current)

Pfizer (Canada)

Guillaume Feugère is an author at Pfizer (United States) specializing in cancer research, radiation oncology, and thrombosis.

Top concepts

MedicineOncologyThrombosisCancer ResearchPharmacotherapyRadiation OncologyHealthHematologyCardiovascular DiseaseStroke

Publications per year

2013–2019

3

Publications

3

A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment

Seth Woodruff, Guillaume Feugère, Paula Abreu et al. · Journal of Thrombosis and Thrombolysis · 2016 · 47 citations · Full text

Thrombosis, Venous Thrombosis, Cardiovascular Disease +10

Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study

Seth Woodruff, Agnes Lee, Marc Carrier et al. · Journal of Thrombosis and Thrombolysis · 2019 · 27 citations · Full text

Active Cancer, Pathology, Pharmacotherapy +18

Anticoagulant use in patients with cancer associated venous thromboembolism: A retrospective cohort study

Elham Rahme, Guillaume Feugère, Caroline Sirois et al. · Thrombosis Research · 2013 · 18 citations

Thrombosis, Retrospective Cohort Study, Venous Thrombosis +11

1–3 of 3